B. Bryant

发表

Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.

T. Waldmann, H. Lane, A. Fojo, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genetic changes in chromosomes 1p and 17p in thyroid cancer progression

T. Giordano, M. Merino, C. Kleer, 2000, Endocrine pathology.

Clinical trial of a humanized anti‐IL‐2/IL‐15 receptor β chain in HAM/TSP

T. Waldmann, S. Jacobson, I. Cortese, 2019, Annals of clinical and translational neurology.

Incidence of loss of heterozygosity at p53 and BRCA1 loci in serous surface carcinoma.

C. Moskaluk, M. Merino, S. Mills, 1999, Human pathology.

Infiltrating micropapillary carcinoma of the breast.

M. Merino, L. Middleton, M. Sobel, 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

The tall cell variant of papillary carcinoma of the thyroid

M. Merino, A. Abati, M. Sobel, 1999, Cancer.

The use of microsatellite instability in the distinction between synchronous endometrial and colonic adenocarcinomas.

M. Merino, C. Otis, M. Quezado, 1999, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

90 Y-Daclizumab (Anti-CD25), High-Dose Carmustine, Etoposide, Cytarabine, and Melphalan Chemotherapy and Autologous Hematopoietic Stem Cell Transplant Yielded Sustained Complete Remissions in 4 Patients with Recurrent Hodgkin’s Lymphoma

T. Waldmann, S. Pittaluga, M. Brechbiel, 2020 .

Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques.

T. Waldmann, H. Lane, M. Roederer, 2011, Blood.

Preclinical and phase I clinical trial of blockade of IL-15 using Mikbeta1 monoclonal antibody in T cell large granular lymphocyte leukemia.

T. Waldmann, T. Fleisher, J. Janik, 2006, Proceedings of the National Academy of Sciences of the United States of America.

CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP.

T. Waldmann, J. Chen, J. Janik, 2011, Blood.

Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemia.

T. Waldmann, M. Raffeld, P. Albert, 2013, Blood.

Autocrine/paracrine cytokine stimulation of leukemic cell proliferation in smoldering and chronic adult T-cell leukemia.

T. Waldmann, V. Nguyễn, J. Janik, 2010, Blood.

IL15 Infusion of Cancer Patients Expands the Subpopulation of Cytotoxic CD56bright NK Cells and Increases NK-Cell Cytokine Release Capabilities

T. Waldmann, Jürgen R. Müller, K. Conlon, 2017, Cancer Immunology Research.

Loss of heterozygosity in P53, BRCA1, and estrogen receptor genes and correlation to expression of p53 protein in ovarian epithelial tumors of different cell types and biological behavior.

M. Merino, D. Kleiner, C. Otis, 2000, Human pathology.

IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion

E. L. Potter, T. Waldmann, S. Pittaluga, 2019, Clinical Cancer Research.

18 Induction of the IL-9 Gene by HTLV-I Tax Stimulates the Spontaneous Proliferation of Primary ATL Cells by a Paracrine Mechanism

T. Waldmann, V. Nguyễn, J. Chen, 2007 .

LOH at the APC/MCC gene (5Q21) is frequent in early stages of non-small cell lung cancer.

M. Merino, J. Balibrea, A. Torres, 1999, Pathology, research and practice.

Identical genetic changes in different histologic components of Wilms' tumors.

A. Lash, M. Merino, M. Deavers, 1997, Journal of the National Cancer Institute.

Frequent E-cadherin Gene Inactivation by Loss of Heterozygosity in Pleomorphic Lobular Carcinoma of the Breast

M. Merino, J. Palacios, M. García-Macías, 2003, Modern Pathology.

Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma

T. Waldmann, M. Yoshioka, P. Green, 2022, Blood advances.

Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma.

L. Staudt, Xin Yu, J. Powell, 2018, Cancer cell.

Genetic analysis of synchronous mucinous tumors of the ovary and appendix.

M. Emmert-Buck, M. Merino, R. Chuaqui, 1996, Human pathology.

Clonality analysis of benign parathyroid lesions by human androgen receptor (HUMARA) gene assay

M. Merino, M. Sobel, X. Sanjuán, 1998, Endocrine pathology.

Pleomorphic Lobular Carcinoma: Morphology, Immunohistochemistry, and Molecular Analysis

M. Merino, L. Middleton, C. Otis, 2000, The American journal of surgical pathology.

90Y-Daclizumab (Anti-CD25), High-Dose Carmustine, Etoposide, Cytarabine, and Melphalan Chemotherapy and Autologous Hematopoietic Stem Cell Transplant Yielded Sustained Complete Remissions in 4 Patients with Recurrent Hodgkin's Lymphoma.

T. Waldmann, S. Pittaluga, M. Brechbiel, 2020, Cancer biotherapy & radiopharmaceuticals.

90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin’s lymphoma

T. Waldmann, E. Jaffe, S. Pittaluga, 2015, Proceedings of the National Academy of Sciences.

Interleukin-15 augments NK cell–mediated ADCC of alemtuzumab in patients with CD52+ T-cell malignancies

T. Waldmann, Jürgen R. Müller, K. Conlon, 2022, Blood advances.

Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies

T. Waldmann, S. Pittaluga, J. Shih, 2021, Journal for ImmunoTherapy of Cancer.

Enhanced efficacy of JAK1 inhibitor with mTORC1/C2 targeting in smoldering/chronic adult T cell leukemia

T. Waldmann, Meili Zhang, Craig J. Thomas, 2020, Translational oncology.

Allelic loss on chromosome 22q in epithelioid sarcomas.

M. Merino, L. Middleton, K. Lane, 1998, Human pathology.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, Brian D. Kelly, 2016, Journal of Immunotherapy for Cancer.

mechanism proliferation of primary adult T-cell leukemia cells by a paracrine Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous

T. Waldmann, J. Chen, J. Janik, 2013 .

Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous proliferation of primary adult T-cell leukemia cells by a paracrine mechanism.

T. Waldmann, J. Chen, J. Janik, 2008, Blood.

Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in Adult T-cell leukemia/lymphoma.

L. Staudt, T. Waldmann, T. Yokota, 2021, Blood.